Bisphosphonates Tied to Small Risk of Atypical Fractures

Despite high prevalence of drug use in patients with atypical fractures, absolute risk is small

WEDNESDAY, May 4 (HealthDay News) -- Among patients with atypical fractures, there is a high prevalence of current bisphosphonate use, but the absolute risk of these fractures is small, according to a study published in the May 5 issue of the New England Journal of Medicine.

Jörg Schilcher, M.D., of Linköping University in Sweden, and colleagues reviewed radiographs of 1,234 women who had a subtrochanteric or shaft fracture and identified 59 patients with atypical fractures. The investigators compared the 59 case patients with 263 control patients who had ordinary subtrochanteric or shaft fractures.

The investigators found that the age-adjusted relative risk of atypical fracture was 47.3, with an increase in absolute risk of five cases per 10,000 patient-years. They found that 78 percent of the case patients and 10 percent of the controls had received bisphosphonates (multivariable adjusted odds ratio [OR], 33.3). The duration of use influenced the risk (OR per 100 daily doses, 1.3). After withdrawal from the drug, the risk decreased by 70 percent per year since last use (OR, 0.28).

"These population-based nationwide analyses may be reassuring for patients who receive bisphosphonates. Although there was a high prevalence of current bisphosphonate use among patients with atypical fractures, the absolute risk was small," the authors write.

One author disclosed financial relationships with Eli Lilly, Amgen, and AddBIO, a company trying to commercialize a method for bisphosphonate coating of implants inserted in bone.

Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events